← FDA Drug Approvals (Drugs@FDA)

NUFYMCO

BLA · Biologics License Application · Sponsor: FORMYCON AG · Approved 2025-12-18

Drug application

FDA Application #

BLA761473

Application type

Biologics License Application

Brand name

NUFYMCO

Generic name

Ranibizumab-Leyk

Active ingredients

RANIBIZUMAB-LEYK

Dosage form

INJECTION

Route

—

Marketing status

Prescription

Sponsor

FORMYCON AG

First approval

2025-12-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown